Senti Biosciences (SNTI) Other Non-Current Assets (2021 - 2025)
Senti Biosciences' quarterly Other Non-Current Assets came in at $19000.0 in Q4 2025, down 81.9% year-on-year from $105000.0 in Q4 2024, and down 44.12% quarter-over-quarter from $34000.0 in Q3 2025.
Senti Biosciences has reported Other Non-Current Assets for 5 years, with the latest figure at $19000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets fell 81.9% year-over-year to $19000.0; the trailing twelve-month figure through Dec 2025 stood at $19000.0 (down 81.9% YoY), and the FY2025 full-year result was $19000.0, down 81.9% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $19000.0, down from $34000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $6.4 million in Q3 2023, with the low at $19000.0 in Q4 2025.
- Average Other Non-Current Assets over 5 years is $2.0 million, with a median of $1.5 million recorded in 2021.
- Year-over-year, Other Non-Current Assets jumped 1585.17% in 2023 and slumped 99.05% in 2025.
- Tracing SNTI's Other Non-Current Assets over 5 years: stood at $3.3 million in 2021, then slumped by 93.58% to $209000.0 in 2022, then jumped by 1585.17% to $3.5 million in 2023, then sank by 97.02% to $105000.0 in 2024, then slumped by 81.9% to $19000.0 in 2025.
- The last three Other Non-Current Assets figures came in at $19000.0 (Q4 2025), $34000.0 (Q3 2025), and $52000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Mar 31, 2025 | 76,000.00 |
| Dec 31, 2024 | 105,000.00 |
| Sep 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 76,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Dec 31, 2023 | 3.52 Mn |
| Sep 30, 2023 | 6.40 Mn |
| Jun 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 3.55 Mn |
| Dec 31, 2022 | 209,000.00 |
| Sep 30, 2022 | 3.30 Mn |
| Jun 30, 2022 | 3.26 Mn |
| Mar 31, 2022 | 3.26 Mn |
| Dec 31, 2021 | 3.26 Mn |
| Sep 30, 2021 | 1.53 Mn |
| Jun 30, 2021 | 1.53 Mn |